Radiogardase (prussian Blue)

   
Google
 
Web NewDrugInformation.com

Radiogardase (prussian Blue)


Drug - Radiogardase (prussian Blue)
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ferric Hexacyanoferrate(ii)
Multiple ingredients are in alphabetical order.

Strength - 500MG
The potency of the active ingredient(s), Ferric Hexacyanoferrate(ii). May repeat for multiple part products.

Applicant - HEYL CHEMISCH
The firm name holding legal responsibility for Radiogardase (prussian Blue). The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021626
The FDA assigned number to Radiogardase (prussian Blue). Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Radiogardase (prussian Blue). Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 2, 2003
The date Radiogardase (prussian Blue) was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Radiogardase (prussian Blue). The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Radiogardase (prussian Blue) is in. Format is RX, OTC, DISCN.

Applicant Full Name - Heyl Chemisch Pharmazeutishe Fabrik
The full name of the firm holding legal responsibility for the new application of Radiogardase (prussian Blue).

Radiogardase (prussian Blue)